Merck
€136.90Change from previous close: +1.82%Absolute change: +€2.45
At a glance
- Revenue growth
- −0.26%
- 2025 vs 2024
- Net income growth
- −6.09%
- 2025 vs 2024
- Net margin
- 12.4%
- 2024: 13.1%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 51,527 | 51,596 | 48,495 | 48,535 | 45,362 |
| Current assets | 13,230 | 13,450 | 12,393 | 12,201 | 10,982 |
| Cash and equivalents | 2,740 | 2,517 | 1,982 | 1,854 | 1,899 |
| Short-term investments | 597 | 559 | 398 | 203 | 100 |
| Receivables | 4,770 | 4,899 | 4,905 | 5,034 | 4,772 |
| Inventory | 4,562 | 4,484 | 4,637 | 4,632 | 3,900 |
| Net property, plant and equipment | 9,940 | 10,025 | 9,056 | 8,204 | 7,217 |
| Goodwill | 17,934 | 19,107 | 17,845 | 18,389 | 17,004 |
| Other intangible assets | 7,660 | 6,349 | 6,551 | 7,335 | 7,612 |
| Long-term investments | 772 | 964 | 808 | 675 | 615 |
| Current liabilities | 9,042 | 11,295 | 8,699 | 9,514 | 10,432 |
| Accounts payable | 1,422 | 1,502 | 1,770 | 1,596 | 1,542 |
| Long-term debt | 10,205 | 6,372 | 8,846 | 8,834 | 7,928 |
| Total debt | 11,952 | 10,271 | 9,864 | 10,398 | — |
| Total liabilities | 22,867 | 21,607 | 21,740 | 22,530 | 23,946 |
| Total equity (incl. minority) | 28,660 | 29,989 | 26,755 | 26,005 | 21,416 |
| Retained earnings | 24,015 | 22,420 | 20,634 | 18,811 | 16,610 |
| Minority interest | 68.0 | 75.0 | 75.0 | 78.0 | 78.0 |
